GALL STONE PULVERIZATION STRATEGY IN PATIENTS TREATED WITH EXTRACORPOREAL LITHOTRIPSY AND FOLLOW-UP RESULTS OF MAINTENANCE TREATMENT WITH URSODEOXYCHOLIC ACID

被引:14
作者
BOSCAINI, M
PICCINNILEOPARDI, M
ANDREOTTI, F
MONTORI, A
机构
[1] UNIV ROMA LA SAPIENZA,DEPT SURG 3,ROME,ITALY
[2] PIO XI CLIN,EXTRACORPOREAL LITHOTRIPSY UNIT,ROME,ITALY
关键词
D O I
10.1136/gut.35.1.117
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Between November 1988 and July 1992 70 patients with radiolucent gall stones were treated with extracorporeal lithotripsy (ESL) and ursodeoxycholic acid (UDCA; mean (SD) dose 11.2 (1.9) mg/kg/day). Fifty three patients have been followed for one year. One week after lithotripsy, 30.6% had completely eliminated all stone fragments from the gall bladder and one year later 93.9% were free of stones. Three factors were considered important in achieving these results. 'Pulverisation' of the stone - that is, its fragmentation into echogenic dust (crystalline aggregates, some few hundred mu in size) or particles similar to grains of sand, smaller than 1 mm in diameter, or both, is required. Secondly, dust and particles were rapidly eliminated, strongly suggesting a mechanical elimination process by physiological gall bladder contractions. Thirdly, there must be chemical dissolution with biliary acids. This therapeutic approach gave excellent results without causing any clinically relevant side effects. The first 20 patients who became free of stones after ESL were given oral bile acid maintenance treatment - 300 mg/ day of UDCA at bedtime, for two years. Ah were asymptomatic and none had suffered a recurrence after two years. In four patients, crystalline aggregates, detected in gall bladder bile by ultrasound, were subsequently dissolved between one and three months after resuming a full dose regimen of UDCA.
引用
收藏
页码:117 / 121
页数:5
相关论文
共 19 条
[1]  
Boscaini M, 1987, Surg Endosc, V1, P41, DOI 10.1007/BF00703087
[2]  
BOSCAINI M, 1989, DORNIER USER, V5, P30
[3]  
BOSCAINI M, 1983, J FRANCAIS ECHOGRAPH, V1, P23
[4]   USE OF EXTERNAL SHOCK-WAVE LITHOTRIPSY AND ADJUVANT URSODIOL FOR TREATMENT OF RADIOLUCENT GALLSTONES - A NATIONAL MULTICENTER STUDY [J].
BURNETT, D ;
ERTAN, A ;
JONES, R ;
OLEARY, JP ;
MACKIE, R ;
ROBINSON, JE ;
SALEN, G ;
STAHLGREN, L ;
VANTHIEL, DH ;
VASSY, L ;
GREENBERGER, N ;
HOFMANN, AF .
DIGESTIVE DISEASES AND SCIENCES, 1989, 34 (07) :1011-1015
[5]  
DOWLING RH, 1987, BILE ACIDS LIVER, P355
[6]   GALLBLADDER STONE FRAGMENTS IN FECES AFTER BILIARY EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY [J].
GREINER, L ;
MUNKS, C ;
HEIL, W ;
JAKOBEIT, C .
GASTROENTEROLOGY, 1990, 98 (06) :1620-1624
[7]  
HOOD K, 1987, GUT, V28, pA139
[8]   GALLSTONE RECURRENCE AFTER MEDICAL DISSOLUTION - AN OVERESTIMATED THREAT [J].
LANZINI, A ;
JAZRAWI, RP ;
KUPFER, RM ;
MAUDGAL, DP ;
JOSEPH, AEA ;
NORTHFIELD, TC .
JOURNAL OF HEPATOLOGY, 1986, 3 (02) :241-246
[9]   LOW-DOSE CHENODIOL TO PREVENT GALLSTONE RECURRENCE AFTER DISSOLUTION THERAPY [J].
MARKS, JW ;
LAN, SP ;
BAUM, RA ;
HABIG, RL ;
HANSON, RF ;
HERSH, T ;
HIGHTOWER, NC ;
HOFMANN, AF ;
LACHIN, JM ;
LASSER, EC ;
MEKHJIAN, H ;
OKUN, R ;
SCHAEFER, RA ;
SCHOENFIELD, LJ ;
SOLOWAY, RD ;
THISTLE, JL ;
THOMAS, FB ;
TYOR, MP .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (03) :376-381
[10]   RECURRENCE AND RE-RECURRENCE OF GALL-STONES AFTER MEDICAL DISSOLUTION - A LONGTERM FOLLOW UP [J].
ODONNELL, LDJ ;
HEATON, KW .
GUT, 1988, 29 (05) :655-658